Epidemiologic & Forecast Models

The future market opportunity for any pipeline product depends on the size of the eligible patient population at the time of launch. We take a data driven, transparent approach to forecasting future eligible patient populations with the capability to consider interim market changes that impact future prevalence. With a deep and comprehensive background in big data analysis and forecasting models, we apply new methods to an under-served discipline of drug and indication market size forecasting.

By creating detailed simulations and end-user-facing tools, we distill the factors that truly matter and help our customers see around corners.